Literature DB >> 30626663

Blood Smears Have Poor Sensitivity for Confirming Borrelia miyamotoi Disease.

Sam R Telford1, Heidi K Goethert2, Philip J Molloy3, Victor Berardi3.   

Abstract

Borrelia miyamotoi disease (BMD) is a newly recognized borreliosis that is cotransmitted by ticks wherever Lyme disease is zoonotic. Unlike Borrelia burgdorferi sensu lato, the agent of Lyme disease, B. miyamotoi is closely related to relapsing fever spirochetes, such as Borrelia hermsi i Some authors have suggested that the disease caused by B. miyamotoi should be considered a hard-tick-transmitted relapsing fever, and thus, the main mode of confirming a diagnosis for that infection, microscopy to analyze a blood smear, may have clinical utility. To determine whether blood smears may detect B. miyamotoi in the blood of acute BMD patients, we made standard malariological thick smears from anticoagulated blood samples that were previously determined to contain this agent (by PCR) and analyzed them for morphological evidence of spirochetes. Spirochetes were not detected in the blood smears from 20 PCR positive patient blood samples after examination of 100 thick smear fields and only 2 of 20 demonstrated spirochetes when the examination was extended to 300 thick smear fields. Inoculation of severe combined immunodeficient (SCID) mice yielded isolates from 5 of 5 samples, but 0 of 3 BALB/c mice became infected. We conclude that in strong contrast to the diagnosis of typical relapsing fever, microscopy of blood smears is not sensitive enough for confirming a diagnosis of BMD but that SCID mouse inoculation could be a useful complement to PCR.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Borrelia miyamotoizzm321990; blood smears; borreliosis; diagnosis; microscopy

Mesh:

Year:  2019        PMID: 30626663      PMCID: PMC6425185          DOI: 10.1128/JCM.01468-18

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology.

Authors:  J Michael Miller; Matthew J Binnicker; Sheldon Campbell; Karen C Carroll; Kimberle C Chapin; Peter H Gilligan; Mark D Gonzalez; Robert C Jerris; Sue C Kehl; Robin Patel; Bobbi S Pritt; Sandra S Richter; Barbara Robinson-Dunn; Joseph D Schwartzman; James W Snyder; Sam Telford; Elitza S Theel; Richard B Thomson; Melvin P Weinstein; Joseph D Yao
Journal:  Clin Infect Dis       Date:  2018-08-31       Impact factor: 9.079

2.  GlpQ: an antigen for serological discrimination between relapsing fever and Lyme borreliosis.

Authors:  T G Schwan; M E Schrumpf; B J Hinnebusch; D E Anderson; M E Konkel
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

3.  Serodiagnosis of Borrelia miyamotoi disease by measuring antibodies against GlpQ and variable major proteins.

Authors:  J Koetsveld; N M Kolyasnikova; A Wagemakers; O A Stukolova; D Hoornstra; D S Sarksyan; M G Toporkova; A J Henningsson; D Hvidsten; W Ang; R Dessau; A E Platonov; J W Hovius
Journal:  Clin Microbiol Infect       Date:  2018-03-14       Impact factor: 8.067

4.  Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1995-08-11       Impact factor: 17.586

5.  Borrelia miyamotoi Disease in the Northeastern United States: A Case Series.

Authors:  Philip J Molloy; Sam R Telford; Hanumara Ram Chowdri; Timothy J Lepore; Joseph L Gugliotta; Karen E Weeks; Mary Ellen Hewins; Heidi K Goethert; Victor P Berardi
Journal:  Ann Intern Med       Date:  2015-07-21       Impact factor: 25.391

Review 6.  Borrelia miyamotoi infection in nature and in humans.

Authors:  P J Krause; D Fish; S Narasimhan; A G Barbour
Journal:  Clin Microbiol Infect       Date:  2015-02-18       Impact factor: 8.067

7.  Multiplex 5' nuclease-quantitative PCR for diagnosis of relapsing fever in a large Tanzanian cohort.

Authors:  Megan E Reller; Emily G Clemens; Steve E Schachterle; George A Mtove; David J Sullivan; J Stephen Dumler
Journal:  J Clin Microbiol       Date:  2011-07-20       Impact factor: 5.948

8.  Meningoencephalitis from Borrelia miyamotoi in an immunocompromised patient.

Authors:  Joseph L Gugliotta; Heidi K Goethert; Victor P Berardi; Sam R Telford
Journal:  N Engl J Med       Date:  2013-01-17       Impact factor: 91.245

Review 9.  Borrelia miyamotoi Disease: Neither Lyme Disease Nor Relapsing Fever.

Authors:  Sam R Telford; Heidi K Goethert; Philip J Molloy; Victor P Berardi; Hanumara Ram Chowdri; Joseph L Gugliotta; Timothy J Lepore
Journal:  Clin Lab Med       Date:  2015-09-18       Impact factor: 1.935

10.  Humans infected with relapsing fever spirochete Borrelia miyamotoi, Russia.

Authors:  Alexander E Platonov; Ludmila S Karan; Nadezhda M Kolyasnikova; Natalya A Makhneva; Marina G Toporkova; Victor V Maleev; Durland Fish; Peter J Krause
Journal:  Emerg Infect Dis       Date:  2011-10       Impact factor: 6.883

View more
  2 in total

Review 1.  Pathogenesis of Relapsing Fever.

Authors:  Job Lopez; Joppe W Hovius; Sven Bergström
Journal:  Curr Issues Mol Biol       Date:  2020-12-29       Impact factor: 2.081

2.  Line Immunoblot Assay for Tick-Borne Relapsing Fever and Findings in Patient Sera from Australia, Ukraine and the USA.

Authors:  Jyotsna S Shah; Song Liu; Iris Du Cruz; Akhila Poruri; Rajan Maynard; Mariia Shkilna; Mykhaylo Korda; Ivan Klishch; Stepan Zaporozhan; Kateryna Shtokailo; Mykhaylo Andreychyn; Raphael B Stricker; Ranjan Ramasamy
Journal:  Healthcare (Basel)       Date:  2019-10-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.